found glp-1 drugs linked to blood pressure risks ๐ GLP-1 use continues to
Description
So I do not like giving one universal number and pretending it fits everyone
Glucagon Receptor Agonist Glucagon receptor has been localized to the brain and pancreas, as well as the heart, kidney, liver, and adipose tissue, suggesting pleiotropic effects in the body [41]

What happens if I miss a dose during titration

"It's temporary shedding." This is what most doctors say

Wu W, Xu H, Wang Z, Mao Y, Yuan L, Luo W, et al
Weight loss can also improve OSA in patients with obesity or overweight as seen with the FDA approval of tirzepatide (Zepbound) and in clinical trials of the investigational GLP-1 agent orforglipron
